ACT, Toray Sign Agreement on Innovative Catheter Technology

Advanced Catheter Therapies and Toray Industries have inked a license agreement to manufacture, market and sell Occlusion Perfusion Catheter. 

The FDA-cleared OPC is a targeted therapeutic agent delivery system for peripheral vascular stenosis and restenosis. 

The OPC is a multi-lumen balloon catheter designed to provide targeted delivery — creating a localized treatment chamber — of various therapeutic and diagnostic agents to the peripheral and coronary vasculature by temporarily occluding a specific region from blood flow. — Joya Patel